Research Papers:

Prognostic significance of osteopontin expression in gastric cancer: a meta-analysis

Xiaobin Gu, Xian-Shu Gao _, Mingwei Ma, Shangbin Qin, Xin Qi, Xiaoying Li, Shaoqian Sun, Hao Yu, Wen Wang and Dong Zhou

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:69666-69673. https://doi.org/10.18632/oncotarget.11936

Metrics: PDF 1759 views  |   HTML 2135 views  |   ?  


Xiaobin Gu1, Xian-Shu Gao1, Mingwei Ma1, Shangbin Qin1, Xin Qi1, Xiaoying Li1, Shaoqian Sun1, Hao Yu1, Wen Wang1, Dong Zhou1

1Department of Radiation Oncology, Peking University First Hospital, Peking University, Beijing, China

Correspondence to:

Xian-Shu Gao, email: [email protected]

Keywords: gastric cancer, osteopontin, meta-analysis, biomarker, prognosis

Received: May 30, 2016     Accepted: September 02, 2016     Published: September 10, 2016


Background: Accumulated studies have exploited the association between osteopontin (OPN) expression and survival of patients with gastric cancer (GC), however, the results were controversial. Thus, we performed a meta-analysis, aiming to investigate the prognostic role of OPN for GC patients and to explore the association between OPN and clinicalpathological features of GC.

Results: A total of ten studies involving 1775 patients were included in final meta-analysis. Of the included studies, nine were conducted on Asian patients and one was performed on Caucasian patients. Regarding OPN detection, immunohistochemistry (IHC) was used on tissue specimens in eight studies and enzyme linked immunosorbent assay (ELISA) was used on plasma specimens in two studies. The pooled data showed that high OPN expression was correlated with poor OS (HR = 1.59, 95% CI: 1.15–2.22, p = 0.006). Subgroup analyses demonstrated that OPN had enhanced prognostic value for Asian patients (HR = 1.64, 95% CI = 1.11–2.41, p = 0.012) and for patients receiving surgical resection (HR = 1.6, 95% CI = 1.04–2.48, p = 0.034). In addition, the results also showed that elevated OPN expression was associated with lymph node metastasis, TNM stage, depth of invasion, tumor size and distant metastasis in GC.

Methods: Relevant studies were retrieved through PubMed, Embase and Web of Science. Combined hazard ratio (HR) and 95% confidence interval (CI) were calculated to assess the association between OPN and overall survival (OS). Subgroup analyses and publication bias were also conducted.

Conclusions: OPN overexpression was correlated with poor OS and clinical features reflecting high aggressiveness in patients with GC. OPN was a promising prognostic biomarker for GC.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11936